Literature DB >> 9799822

Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis.

A Bagur1, C Mautalen, J Findor, J Sorda, J Somoza.   

Abstract

The objectives of this work was to (1) study the bone mineral density (BMD) of the lumbar spine, total skeleton, and body composition in patients with primary biliary cirrhosis (PBC) and (2) evaluate the risk factors (premature menopause, stages of the disease, hyperbilirubinemia) and bone and liver biochemical parameters for the development of osteoporosis. We studied 23 women with a compatible diagnosis of PBC. The BMD and body composition were evaluated by X-ray absorptiometry (Lunar DPX-L). The average age of the population was 56.7 +/- 10.2 years. The BMD of the lumbar spine and of the total skeleton was 1.3 SDs below the normal population matched for sex and age. In the total skeleton, the legs were the most severely affected area (Z score -1.5). The body composition showed no significant difference compared with the normal population. The BMD of 56% of the patients was less than -2.5 SDs from the average normal young values. Patients with a history of vertebral fractures had diminished mineral density of the lumbar spine, as did those who had had no fractures. Of the risk factors studied, patients with premature menopause had a lower bone mass compared with patients with normal menopausal age (Z score of the total skeleton was -2.1 +/- 1.8 versus -1.1 +/- 1.0) but the difference did not reach statistical significance. The bone mass was not affected in patients with regular menstrual cycles. There were no statistically significant differences in high levels of bilirubin, advanced stages of the disease, or the biochemical variables studied. It is concluded that patients with primary biliary cirrhosis present diminished cortical and trabecular bone mass, whereas body composition was unaffected. Premature hormone deficit, possibly triggered by the chronic hepatic pathology, is a contributing factor to the osteoporosis in this population.

Entities:  

Mesh:

Year:  1998        PMID: 9799822     DOI: 10.1007/s002239900545

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  10 in total

Review 1.  Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

2.  Chronic non-cholestatic liver disease is not associated with an increased fracture rate in children.

Authors:  Jerzy Konstantynowicz; Dariusz M Lebensztejn; Elzbieta Skiba; Maria E Sobaniec-Lotowska; Pawel Abramowicz; Janina Piotrowska-Jastrzebska; Maciej Kaczmarski
Journal:  J Bone Miner Metab       Date:  2010-09-14       Impact factor: 2.626

3.  Association between total bilirubin and bone mineral density level in adolescents.

Authors:  Jing Wu; Jiali Su; Yangyang Wang; Jianfeng Chen; Yuanyuan Shang; Jing Li
Journal:  BMC Musculoskelet Disord       Date:  2022-07-04       Impact factor: 2.562

Review 4.  Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges.

Authors:  Nicola Pugliese; Ivan Arcari; Alessio Aghemo; Andrea G Lania; Ana Lleo; Gherardo Mazziotti
Journal:  World J Gastroenterol       Date:  2022-04-14       Impact factor: 5.374

Review 5.  Current understanding of osteoporosis associated with liver disease.

Authors:  Inaam A Nakchbandi; Schalk W van der Merwe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11       Impact factor: 46.802

6.  Osteoporosis in chronic liver disease: a case-control study.

Authors:  Ghizlane Wariaghli; Aziza Mounach; Lahsen Achemlal; Imane Benbaghdadi; Aziz Aouragh; Ahmed Bezza; Abdellah El Maghraoui
Journal:  Rheumatol Int       Date:  2009-07-28       Impact factor: 2.631

7.  Use of calcaneal ultrasound and biochemical markers to assess the density and metabolic state of the bones of adults with hepatic cirrhosis.

Authors:  Dorothy J VanderJagt; Edith Okeke; Christine Calvin; Carmen Troncoso; Michael Crossey; Robert H Glew
Journal:  J Natl Med Assoc       Date:  2007-09       Impact factor: 1.798

8.  Primary biliary cirrhosis and osteoporosis: a case-control study.

Authors:  Aziza Mounach; Zhor Ouzzif; Ghizlane Wariaghli; Lahsen Achemlal; Imane Benbaghdadi; Aziz Aouragh; Ahmed Bezza; Abdellah El Maghraoui
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

Review 9.  Risk Factors and Management of Osteoporosis Post-Transplant.

Authors:  Karthik Kovvuru; Swetha Rani Kanduri; Pradeep Vaitla; Rachana Marathi; Shiva Gosi; Desiree F Garcia Anton; Franco H Cabeza Rivera; Vishnu Garla
Journal:  Medicina (Kaunas)       Date:  2020-06-19       Impact factor: 2.430

10.  Risk factors for osteoporosis in liver cirrhosis patients measured by transient elastography.

Authors:  Jian-Ping Zheng; Hai-Xiong Miao; Shao-Wei Zheng; Wei-le Liu; Chu-Qun Chen; Hao-Bo Zhong; Sheng-Fa Li; Yong-Ping Fang; Chun-Han Sun
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.